Episode 29 - Daphne Koller
Daphne Koller, formerly at Stanford University and cofounder of the online education company, Coursera, talks this week about using machine-learning to develop new drugs. Her approach is to use machine learning to accuratley identify cellular or genetic targets for treatment. The field is just getting started but…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Eye On A.I.
See all episodes →
57%Inside Ukraine's Azov Drone R&D: The Engineer Building AI Weapons 18 km From the Front Line | Alexander Palamarchuk
55%In 5 to 10 Years, Using Weapons Without AI Will Be Considered Unethical | Yaroslav Azhnyuk, The Fourth Law
53%American Companies Have 36 Months to Go AI-Native or Get Left Behind | Drew Cukor, TWG AI
Similar episodes from other shows
More like Eye On A.I. →
#93 – Daphne Koller: Biomedicine and Machine Learning
When AI and Genomics Collide
EP 29: AlphaFold, AlphaGenome, And the Scientific Revolution
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.